Hollsteen
← Veeva

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 FY2016: $108M · 10-Q 0001564590-15-004860 filed Jun 4, 2015Cash and equivalents · Q2 FY2016: $120M · 10-Q 0001564590-15-007757 filed Sep 4, 2015Cash and equivalents · Q3 FY2016: $109M · 10-Q 0001564590-15-011387 filed Dec 10, 2015Cash and equivalents · Q4 FY2016: $132M · 10-K 0001564590-16-015753 filed Mar 31, 2016Cash and equivalents · Q1 FY2017: $246M · 10-Q 0001564590-16-020379 filed Jun 8, 2016Cash and equivalents · Q2 FY2017: $210M · 10-Q 0001564590-16-025058 filed Sep 8, 2016Cash and equivalents · Q3 FY2017: $206M · 10-Q 0001564590-16-030006 filed Dec 8, 2016Cash and equivalents · Q4 FY2017: $218M · 10-K 0001564590-17-005637 filed Mar 30, 2017Cash and equivalents · Q1 FY2018: $366M · 10-Q 0001564590-17-012336 filed Jun 8, 2017Cash and equivalents · Q2 FY2018: $409M · 10-Q 0001564590-17-018414 filed Sep 7, 2017Cash and equivalents · Q3 FY2018: $311M · 10-Q 0001564590-17-024561 filed Dec 6, 2017Cash and equivalents · Q4 FY2018: $320M · 10-K 0001564590-18-007164 filed Mar 30, 2018Cash and equivalents · Q1 FY2019: $460M · 10-Q 0001564590-18-015244 filed Jun 7, 2018Cash and equivalents · Q2 FY2019: $512M · 10-Q 0001564590-18-022767 filed Sep 6, 2018Cash and equivalents · Q3 FY2019: $468M · 10-Q 0001564590-18-030635 filed Dec 7, 2018Cash and equivalents · Q4 FY2019: $551M · 10-K 0001564590-19-009853 filed Mar 28, 2019Cash and equivalents · Q1 FY2020: $748M · 10-Q 0001564590-19-021933 filed Jun 6, 2019Cash and equivalents · Q2 FY2020: $827M · 10-Q 0001628280-19-011445 filed Sep 5, 2019Cash and equivalents · Q3 FY2020: $893M · 10-Q 0001628280-19-014779 filed Dec 5, 2019Cash and equivalents · Q4 FY2020: $477M · 10-K 0001628280-20-004385 filed Mar 30, 2020Cash and equivalents · Q1 FY2021: $721M · 10-Q 0001628280-20-008982 filed Jun 4, 2020Cash and equivalents · Q2 FY2021: $796M · 10-Q 0001628279-20-000207 filed Sep 8, 2020Cash and equivalents · Q3 FY2021: $634M · 10-Q 0001628280-20-017286 filed Dec 9, 2020Cash and equivalents · Q4 FY2021: $731M · 10-K 0001393052-21-000015 filed Mar 30, 2021Cash and equivalents · Q1 FY2022: $1.2B · 10-Q 0001393052-21-000028 filed Jun 4, 2021Cash and equivalents · Q2 FY2022: $1.1B · 10-Q 0001393052-21-000034 filed Sep 3, 2021Cash and equivalents · Q3 FY2022: $1.1B · 10-Q 0001393052-21-000040 filed Dec 3, 2021Cash and equivalents · Q4 FY2022: $1.1B · 10-K 0001393052-22-000017 filed Mar 30, 2022Cash and equivalents · Q1 FY2023: $1.2B · 10-Q 0001393052-22-000025 filed Jun 3, 2022Cash and equivalents · Q2 FY2023: $1.1B · 10-Q 0001393052-22-000036 filed Sep 2, 2022Cash and equivalents · Q3 FY2023: $865M · 10-Q 0001393052-22-000048 filed Dec 7, 2022Cash and equivalents · Q4 FY2023: $886M · 10-K 0001393052-23-000025 filed Mar 30, 2023Cash and equivalents · Q1 FY2024: $1.1B · 10-Q 0001393052-23-000034 filed Jun 2, 2023Cash and equivalents · Q2 FY2024: $743M · 10-Q 0001393052-23-000051 filed Sep 1, 2023Cash and equivalents · Q3 FY2024: $744M · 10-Q 0001393052-23-000066 filed Dec 7, 2023Cash and equivalents · Q4 FY2024: $703M · 10-K 0001393052-24-000013 filed Mar 25, 2024Cash and equivalents · Q1 FY2025: $1.2B · 10-Q 0001393052-24-000024 filed Jun 4, 2024Cash and equivalents · Q2 FY2025: $1.2B · 10-Q 0001393052-24-000062 filed Sep 4, 2024Cash and equivalents · Q3 FY2025: $1.0B · 10-Q 0001393052-24-000075 filed Dec 9, 2024Cash and equivalents · Q4 FY2025: $1.1B · 10-K 0001393052-25-000022 filed Mar 24, 2025Cash and equivalents · Q1 FY2026: $2.0B · 10-Q 0001393052-25-000042 filed Jun 2, 2025Cash and equivalents · Q2 FY2026: $1.9B · 10-Q 0001393052-25-000067 filed Aug 29, 2025Cash and equivalents · Q3 FY2026: $1.7B · 10-Q 0001393052-25-000078 filed Nov 21, 2025Cash and equivalents · Q4 FY2026: $1.4B · 10-K 0001393052-26-000014 filed Mar 20, 2026Cash and equivalents · Q1 FY2027: $1.9B · 10-Q 0001393052-26-000026 filed Jun 5, 2026Cash and equivalents · Q2 FY2027: $1.8B · 10-Q 0001393052-26-000036 filed Aug 27, 20266341,8121081,965Q1 FY2016Q2 FY2027Q3 FY2021
$MCash and equivalents · Q3 FY2020: $893M · 10-Q 0001628280-19-014779 filed Dec 5, 2019Cash and equivalents · Q4 FY2020: $477M · 10-K 0001628280-20-004385 filed Mar 30, 2020Cash and equivalents · Q1 FY2021: $721M · 10-Q 0001628280-20-008982 filed Jun 4, 2020Cash and equivalents · Q2 FY2021: $796M · 10-Q 0001628279-20-000207 filed Sep 8, 2020Cash and equivalents · Q3 FY2021: $634M · 10-Q 0001628280-20-017286 filed Dec 9, 2020Cash and equivalents · Q4 FY2021: $731M · 10-K 0001393052-21-000015 filed Mar 30, 2021Cash and equivalents · Q1 FY2022: $1.2B · 10-Q 0001393052-21-000028 filed Jun 4, 2021Cash and equivalents · Q2 FY2022: $1.1B · 10-Q 0001393052-21-000034 filed Sep 3, 20216341,0658931,185Q3 FY2020Q2 FY2022Q3 FY2021
Q3 FY2021
634$M
All values (46)
PeriodValue ($M)Status
Q2 FY20271,812reported
Q1 FY20271,897reported
Q4 FY20261,421reported
Q3 FY20261,660reported
Q2 FY20261,930reported
Q1 FY20261,965reported
Q4 FY20251,119reported
Q3 FY20251,045reported
Q2 FY20251,166reported
Q1 FY20251,197reported
Q4 FY2024703reported
Q3 FY2024744reported
Q2 FY2024743reported
Q1 FY20241,094reported
Q4 FY2023886reported
Q3 FY2023865reported
Q2 FY20231,140reported
Q1 FY20231,240reported
Q4 FY20221,138reported
Q3 FY20221,150reported
Q2 FY20221,065reported
Q1 FY20221,185reported
Q4 FY2021731reported
Q3 FY2021634reported
Q2 FY2021796reported
Q1 FY2021721reported
Q4 FY2020477reported
Q3 FY2020893reported
Q2 FY2020827reported
Q1 FY2020748reported
Q4 FY2019551reported
Q3 FY2019468reported
Q2 FY2019512reported
Q1 FY2019460reported
Q4 FY2018320reported
Q3 FY2018311reported
Q2 FY2018409reported
Q1 FY2018366reported
Q4 FY2017218reported
Q3 FY2017206reported
Q2 FY2017210reported
Q1 FY2017246reported
Q4 FY2016132reported
Q3 FY2016109reported
Q2 FY2016120reported
Q1 FY2016108reported

CSV with all sources · Technical ID: cash

More metrics for Veeva

Income statement

Per share

Balance sheet

Cash flow

Revenue by segment/product/region

Sources & calculation
Value
$634M
Period
Q3 FY2021, ended Oct 31, 2020 · as of Oct 31, 2020 (balance as of date, not a sum)
Source
10-Q, filed Dec 9, 2020 · 0001628280-20-017286
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$634MDec 9, 202010-Q 0001628280-20-017286reported · confidence 1. · current